Nurturing biotech ventures

.

BioElevate

Turning early-stage health innovation into commercial direction

You’ve generated something novel in the lab. You may have recently filed — or will be preparing to file — a patent. Now comes the harder question: how does this become a real-world solution?

BioElevate is a two-day intensive designed for researchers who are new to commercialisation and ready to take their first structured step from discovery toward real-world impact.

Expression of Interest

Why BioElevate?

.
Over two in-person days, you will:

  • Clearly define and articulate your unmet clinical need

  • Identify your critical stakeholders and decision-makers

  • Develop a strong, defensible value proposition

  • Understand market segmentation and early opportunity sizing (TAM/SAM/SOM)

  • Map revenue streams and commercial pathways

  • Gain practical clarity on regulation, IP positioning, and funding options

  • Build your first structured pitch narrative

  • Test your pitch with experienced VCs in a closed-door session designed for honest, constructive feedback.

Expression of Interest

You don’t need a company, ABN, or finished product, just a compelling idea and the drive to take it further.

.

Who is it for?

BioElevate is designed for founders, researchers, or early-stage teams in:

+ Therapeutics

+ Medtech

+ Diagnostics

+ Software as a Medical Device (SaMD)

.

Eligibility

To be eligible to participate in Elevate, you must:

+ Be actively developing a technology or solution

+ Have filed or thinking to file a patent

+ Be at early Technology Readiness Level (typically TRL 1–3)

Be new to commercialisation and ready to engage in the process

How it works

Find the right fit

Tell us your idea and where are you at

Assessment

We review your application and invite successful applicants to join

Get ready

Complete onboarding and online prep

Elevate workshops

Dive into a fast-paced, hands on experience

Stay connected

Post-program support and opportunities

The 2026 Facilitators

.

Dr Patricia Vietheer
Senior Director, R&D Strategy & Planning at Biointelect

At Biointelect, Patricia leads the R&D Strategy & Planning team, supporting a wide range of clients from universities, research institutions, government, start-up companies, biotech, medtech and pharma companies. She has led numerous projects at Biointelect in commercialisation strategy, business case development, planning and execution for key clients. She is particularly passionate about helping clients streamline their path to market using strategic project management techniques and thus commercialising their novel discoveries.

.

A/Prof Daryl Cheng
Consultant Paediatrician, Department of General Medicine at The Royal Children’s Hospital Melbourne

Associate Professor Daryl Cheng is a medical executive leader, digital health consultant and practicing consultant paediatrician and clinical informatician at The Royal Children’s Hospital Melbourne (RCH) and Head of Paediatrics, Cabrini Health. Chief Medical Officer at Magentus, advising startups on digital health, data analytics, and transformation. He also contributes to systems innovation through roles with the Melbourne Children’s Campus Centre for Health Analytics and the RCH Digital Innovation & Electronic Medical Record (EMR) Team.

Guest Speakers 2026

.
Ian Rourke, PhD Partner at FB Rice
.
Betty Zhang Investment Manager at Boson Ventures
.
Dr Emil Bujak Partner and Head of Life Sciences
.
Dr Joey Man Investment Associate at Tenmile
.
Jon Bernardini Co-Founder & Chief Executive Officer of Proxima Bio

The next BioElevate takes place in 2027

Early applications are strongly encouraged! Places are limited and interest is high. If you have an idea with the potential to make a real impact, now is the time to take the next step.

Submit an Expression of Interest for BioElevate 2027 today and we'll be in touch once applications open.

Expression of Interest